Capricor Therapeutics (CAPR) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for Capricor Therapeutics (CAPR) over the last 12 years, with Q3 2025 value amounting to $1.8 million.
- Capricor Therapeutics' Other Gross PP&E Adjustments fell 7468.01% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 7468.01%. This contributed to the annual value of $7.7 million for FY2024, which is 3467.9% up from last year.
- According to the latest figures from Q3 2025, Capricor Therapeutics' Other Gross PP&E Adjustments is $1.8 million, which was down 7468.01% from $11.2 million recorded in Q2 2025.
- In the past 5 years, Capricor Therapeutics' Other Gross PP&E Adjustments ranged from a high of $11.2 million in Q2 2025 and a low of -$269536.0 during Q4 2021
- Over the past 5 years, Capricor Therapeutics' median Other Gross PP&E Adjustments value was $4.0 million (recorded in 2023), while the average stood at $4.3 million.
- As far as peak fluctuations go, Capricor Therapeutics' Other Gross PP&E Adjustments tumbled by 11717.42% in 2021, and later surged by 136872.89% in 2022.
- Quarter analysis of 5 years shows Capricor Therapeutics' Other Gross PP&E Adjustments stood at -$269536.0 in 2021, then skyrocketed by 1368.73% to $3.4 million in 2022, then skyrocketed by 67.17% to $5.7 million in 2023, then soared by 34.68% to $7.7 million in 2024, then plummeted by 76.8% to $1.8 million in 2025.
- Its Other Gross PP&E Adjustments was $1.8 million in Q3 2025, compared to $11.2 million in Q2 2025 and $8.7 million in Q1 2025.